<DOC>
	<DOC>NCT01119235</DOC>
	<brief_summary>A new tablet form of PF-04531083 has been manufactured. Previously the compound was administered as a solution/suspension to healthy volunteers. This study will investigate the pharmacokinetics of PF-044531083 in tablet form and compare with the pharmacokinetics obtained, with the same dosing regimen, with the solution/suspension.</brief_summary>
	<brief_title>A Study To Observe The Performance Of A Tablet Form Of PF-04531083 As Evidenced By The Concentration Of PF-04531083 In The Blood With Time Following Oral Administration To Healthy Volunteers.</brief_title>
	<detailed_description />
	<mesh_term>Chronic Pain</mesh_term>
	<criteria>Young Healthy volunteers Elderly volunteers Patients with any existing medical conditions considered likely to impinge on study execution</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>August 2010</verification_date>
	<keyword>Pharmacokinetics</keyword>
	<keyword>tablet performance</keyword>
	<keyword>healthy volunteers</keyword>
	<keyword>open label</keyword>
</DOC>